BiotechTube
Home/Immusoft/Sean Ainsworth
SA

Sean Ainsworth

Chief Executive Officer & Chairman

Immusoft

Therapeutic Areas

Rare Genetic DiseasesLysosomal Storage Disorders

Immusoft Pipeline

DrugIndicationPhase
ISP-001Mucopolysaccharidosis type I (MPS I)Preclinical

Leadership Team at Immusoft

RS
Robert Sikorski, M.D., Ph.D.
Chief Medical Officer
RH
Rob Hayes, Ph.D.
Chief Scientific Officer
View full Immusoft profile